A Multicenter Phase I/II Study of the BCNU Implant (Gliadel (®) Wafer) for Japanese Patients with Malignant Gliomas

Carmustine (BCNU) implants (Gliadel(®) Wafer, Eisai Inc., New Jersey, USA) for the treatment of malignant gliomas (MGs) were shown to enhance overall survival in comparison to placebo in controlled clinical trials in the United States and Europe. A prospective, multicenter phase I/II study involving...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neurol Med Chir (Tokyo)
Hoofdauteurs: AOKI, Tomokazu, NISHIKAWA, Ryo, SUGIYAMA, Kazuhiko, NONOGUCHI, Naosuke, KAWABATA, Noriyuki, MISHIMA, Kazuhiko, ADACHI, Jun-ichi, KURISU, Kaoru, YAMASAKI, Fumiyuki, TOMINAGA, Teiji, KUMABE, Toshihiro, UEKI, Keisuke, HIGUCHI, Fumi, YAMAMOTO, Tetsuya, ISHIKAWA, Eiichi, TAKESHIMA, Hideo, YAMASHITA, Shinji, ARITA, Kazunori, HIRANO, Hirofumi, YAMADA, Shinobu, MATSUTANI, Masao
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: The Japan Neurosurgical Society 2014
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4533485/
https://ncbi.nlm.nih.gov/pubmed/24739422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2176/nmc.oa2013-0112
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items